SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Solventum Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$85.05−0.76 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
Solventum Corp revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg | $1.37B | $1.23B | $1.24B | $1.21B | $1.22B | $1.16B | $1.17B | $1.18B | $1.16B | $1.12B | $1.17B | $1.18B | 62.1% | +12.6% |
| Dental Solutions | $396.00M | $354.00M | $343.00M | $340.00M | $338.00M | $328.00M | $316.00M | $313.00M | $331.00M | $335.00M | $306.00M | $331.00M | 17.9% | +17.2% |
| Health Information Systems | $354.00M | $342.00M | $348.00M | $345.00M | $339.00M | $329.00M | $335.00M | $326.00M | $328.00M | $317.00M | $332.00M | $321.00M | 16.0% | +4.4% |
| Purification and Filtration | $0 | $0 | $0 | $128.00M | $189.00M | $180.00M | $177.00M | $180.00M | $238.00M | $245.00M | $230.00M | $242.00M | 0.0% | -100.0% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg | $355.00M | $161.00M | $191.00M | $203.00M | $210.00M | $206.00M | $209.00M | $243.00M | $214.00M | $221.00M | $278.00M | $307.00M | +69.0% |
| Health Information Systems | $145.00M | $130.00M | $133.00M | $134.00M | $120.00M | $109.00M | $114.00M | $105.00M | $111.00M | $101.00M | $119.00M | $114.00M | +20.8% |
| Dental Solutions | $131.00M | $87.00M | $84.00M | $87.00M | $96.00M | $78.00M | $73.00M | $74.00M | $93.00M | $110.00M | $93.00M | $114.00M | +36.5% |
| Purification and Filtration | $0 | $0 | $0 | $26.00M | $43.00M | $27.00M | $12.00M | $19.00M | $19.00M | $39.00M | -$23.00M | $48.00M | -100.0% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of product | $1.70B | $1.51B | $1.49B | $1.59B | $1.67B | $1.60B | $1.58B | $1.61B | $1.61B | $1.55B | $1.55B | $1.59B | 76.9% | +1.8% |
| Cost of software and rentals | $511.00M | $493.00M | $508.00M | $502.00M | $493.00M | $473.00M | $493.00M | $474.00M | $476.00M | $463.00M | – | – | 23.1% | +3.7% |
| Cost of software and rentals | – | – | – | – | – | – | – | $474.00M | $476.00M | $463.00M | – | $481.00M | – | – |
By region
From the segment and revenue-disaggregation notes of Solventum's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.